Alice Chung

Summary

Publications

  1. doi request reprint Axillary staging in the neoadjuvant setting
    Alice Chung
    Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
    Ann Surg Oncol 17:2401-10. 2010
  2. doi request reprint Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography
    Alice Chung
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:2119-25. 2010
  3. doi request reprint Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients
    Alice Chung
    Department of Surgery, Division of Surgical Oncology at Cedars Sinai Medical Center, Los Angeles, CA, USA
    Ann Surg Oncol 19:2600-6. 2012
  4. doi request reprint Intraductal fibroadenomatosis: an unusual variant of fibroadenoma
    Alice Chung
    Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California, USA
    Breast J 14:193-5. 2008
  5. doi request reprint Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
    Alice Chung
    Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, NY 10065, USA
    Ann Surg Oncol 15:2728-33. 2008
  6. ncbi request reprint Preoperative FDG-PET for axillary metastases in patients with breast cancer
    Alice Chung
    Saul and Joyce Brandman Breast Center, Cedars Sinai Medical Center, Los Angeles, Calif, USA
    Arch Surg 141:783-8; discussion 788-9. 2006
  7. ncbi request reprint Preliminary results: double lumpectomies for multicentric breast carcinoma
    Nimmi S Kapoor
    John Wayne Cancer Institute, Santa Monica, California, USA
    Am Surg 78:1345-8. 2012
  8. ncbi request reprint Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
    Jaime Shamonki
    Department of Pathology, Saint John s Health Center, Santa Monica, CA, USA
    Ann Surg Oncol 20:4137-44. 2013
  9. pmc Current status of anti-human epidermal growth factor receptor 2 therapies: predicting and overcoming herceptin resistance
    Alice Chung
    Department of Surgery, Division of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Clin Breast Cancer 13:223-32. 2013
  10. ncbi request reprint Breast-conserving therapy for triple-negative breast cancer
    Alexandra Gangi
    Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California
    JAMA Surg 149:252-8. 2014

Collaborators

Detail Information

Publications16

  1. doi request reprint Axillary staging in the neoadjuvant setting
    Alice Chung
    Department of Surgical Oncology, John Wayne Cancer Institute at Saint John s Health Center, Santa Monica, CA, USA
    Ann Surg Oncol 17:2401-10. 2010
    ..Finally, we propose a treatment algorithm for patients undergoing NAC on the basis of the current data...
  2. doi request reprint Incidental breast lesions identified by 18F-fluorodeoxyglucose-positron emission tomography
    Alice Chung
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 17:2119-25. 2010
    ..We describe our experience with breast incidentalomas in a large series of PET scans performed for patients without a known history of breast cancer...
  3. doi request reprint Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients
    Alice Chung
    Department of Surgery, Division of Surgical Oncology at Cedars Sinai Medical Center, Los Angeles, CA, USA
    Ann Surg Oncol 19:2600-6. 2012
    ..This study's objective was to compare clinicopathologic characteristics of BCa patients who elected CPM to those who elected unilateral total mastectomy (UTM) and to determine whether CPM improved survival...
  4. doi request reprint Intraductal fibroadenomatosis: an unusual variant of fibroadenoma
    Alice Chung
    Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California, USA
    Breast J 14:193-5. 2008
    ..This may represent an unusual variant of fibroadenoma that has not been described in the literature and its likelihood of recurrence is unknown...
  5. doi request reprint Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
    Alice Chung
    Department of Surgery, Breast Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, MRI 1026, New York, NY 10065, USA
    Ann Surg Oncol 15:2728-33. 2008
    ..Here we determine how frequently a positive SLN would be missed by the 10% rule...
  6. ncbi request reprint Preoperative FDG-PET for axillary metastases in patients with breast cancer
    Alice Chung
    Saul and Joyce Brandman Breast Center, Cedars Sinai Medical Center, Los Angeles, Calif, USA
    Arch Surg 141:783-8; discussion 788-9. 2006
    ..Fludeoxyglucose F 18 (FDG) positron emission tomography (PET) can be used to predict axillary node metastases...
  7. ncbi request reprint Preliminary results: double lumpectomies for multicentric breast carcinoma
    Nimmi S Kapoor
    John Wayne Cancer Institute, Santa Monica, California, USA
    Am Surg 78:1345-8. 2012
    ..This small series suggests that "double lumpectomy" may be considered for multicentric invasive breast carcinoma in carefully selected patients with favorable tumors who desire breast conservation...
  8. ncbi request reprint Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
    Jaime Shamonki
    Department of Pathology, Saint John s Health Center, Santa Monica, CA, USA
    Ann Surg Oncol 20:4137-44. 2013
    ..We aimed to determine if larger samples of tissue obtained by core needle biopsy can more reliably predict the true benign nature of a papilloma...
  9. pmc Current status of anti-human epidermal growth factor receptor 2 therapies: predicting and overcoming herceptin resistance
    Alice Chung
    Department of Surgery, Division of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Clin Breast Cancer 13:223-32. 2013
    ..We introduce the basal molecular subtype as a predictor of increased risk in HER2+ breast cancer and a possible alternative cause of drug resistance. ..
  10. ncbi request reprint Breast-conserving therapy for triple-negative breast cancer
    Alexandra Gangi
    Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California
    JAMA Surg 149:252-8. 2014
    ....
  11. doi request reprint Prognostic value of basal phenotype in HER2-overexpressing breast cancer
    Sanjay P Bagaria
    Department of Surgical Oncology, John Wayne Cancer Institute, Santa Monica, CA, USA
    Ann Surg Oncol 19:935-40. 2012
    ..We investigated the clinical relevance of this basal-HER2+ subtype within HER2-overexpressing breast tumors...
  12. ncbi request reprint In vivo cytometry: a spectrum of possibilities
    Alice Chung
    Minimally Invasive Surgical Technologies Institute and Department of Surgery, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Cytometry A 69:142-6. 2006
    ....
  13. doi request reprint B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis
    Takaaki Arigami
    Department of Molecular Oncology, John Wayne Cancer Institute, Saint John s Health Center, Santa Monica, CA, USA
    Ann Surg 252:1044-51. 2010
    ..We hypothesized that B7-H3, a coinhibitory factor, is expressed by primary breast cancer cells and associated with metastasis to regional tumor-draining lymph nodes...
  14. ncbi request reprint The impact of MRI on the treatment of DCIS
    Alice Chung
    Saul and Joyce Brandman Breast Center, Cedars Sinai Medical Center, Los Angeles, California, USA
    Am Surg 71:705-10. 2005
    ..Breast MRI is a sensitive diagnostic imaging tool in patients with DCIS. However, any suspicious finding should be biopsied before a definitive operation is planned...
  15. pmc Microbial dysbiosis is associated with human breast cancer
    Caiyun Xuan
    Dirks Dougherty Laboratory for Cancer Research, Department of Translational Immunology, John Wayne Cancer Institute, Santa Monica, California, United States of America
    PLoS ONE 9:e83744. 2014
    ..Our findings suggest a previously unrecognized link between dysbiosis and breast cancer which has potential diagnostic and therapeutic implications. ..
  16. ncbi request reprint Functional domains of CCN1 (Cyr61) regulate breast cancer progression
    James O'Kelly
    Division of Hematology Oncology, Cedars Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA
    Int J Oncol 33:59-67. 2008
    ....